SSI Partners with Source BioScience to Offer RT-PCR Swab Testing in Fight Against Covid-19

SSI PCR swab test

In our efforts to help mitigate the devastating effects of the Covid-19 virus, we have partnered with Source BioScience to offer RT-PCR swab testing for global energy companies.

The carefully designed RT-PCR testing procedure has been developed to help mitigate the risk of spreading the Covid-19 virus to personnel onsite and operations offshore. The test identifies if a person has the Covid-19 virus and as well as being 99.9% accurate, it carries the CE IVD mark.

The RT-PCR testing procedure is comprehensive and carried out by experienced health care professionals. A routine procedure will involve RT-PCR testing at an onshore location prior to any personnel’s deployment offshore. A registered Health Care Professional (HCP), typically a nurse, is stationed to take a swab from personnel in a designated testing room at staggered intervals.

Once the testing is complete, the swab samples are transported to the Source BioScience laboratory in Nottingham and in turn processed, with results becoming available within 24 hours of arrival. The results are then communicated via an online portal, further encrypted and issued to the company point of contact for further dissemination.

On the partnership, our Director Jules Rawles explains how ‘working with such a highly accredited state of the art laboratory and one that provides RT-PCR testing services to the NHS is a great way to help combat the spread of Covid-19. We are grateful for the opportunity to assist in mitigating the damaging effects of the virus.”

The testing is conducted from Source BioScience’s highly accredited ISO:15189:2012 laboratory that is Care Quality Commission (CQC) registered. Source BioScience are an international provider of integrated state of the art laboratory services and products for the RT-PCR test.

Alongside our Clinical Governance provided by Dr Paddy Morgan (Emergency Doctor of the Year 2018) and Paul Savage (OBE), the testing is a suitable way to mitigate the risk of spreading the virus and potentially causing costly disruptions to operations on and offshore.

As part of a comprehensive range of COVID-19 medical services, we have recently formed a strategic partnership with Texo Accommodation, part of Texo Group of companies, to deliver modular Coronavirus screening and testing stations in the UK. The range of flexible, modular buildings which offer high-quality, rapidly deployed welfare facilities can be quickly deployed to locations including ports and heliports.

For more information regarding the RT-PCR testing service, contact Dave Thompson at


Leave a Reply